The Continuous Flow Total Artificial Heart in Clinical Practice
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21230%2F15%3A00234295" target="_blank" >RIV/68407700:21230/15:00234295 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/68407700:21230/15:00234300 RIV/68407700:21230/15:00234296
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The Continuous Flow Total Artificial Heart in Clinical Practice
Popis výsledku v původním jazyce
My minireview describes an inventive medical device for the replacement of pulsatile circulation by pulseless circulation for patients awaiting heart transplantation. The Continuous flow total artificial heart (CFTAH) is a device consisting of two continuous ventricular assist devices that produce pulseless flow into both systemic and pulmonary circulation. Its utilization is not yet widespread. The Continuous flow total artificial heart has only been implanted in humans three times as an off-label use of a ventricular assist device. All three men have been supported by chronic pulseless flow. The issue of chronic pulseless vs. chronic pulsatile blood flow and its effects on organs and tissue perfusion has been debated in medical and biomedical scientific journals for decades. There are many animal studies, views of many scientists and many hypotheses, but no clear answer to the basic question: will a person be able live a quality life with pulseless flow for months and years?
Název v anglickém jazyce
The Continuous Flow Total Artificial Heart in Clinical Practice
Popis výsledku anglicky
My minireview describes an inventive medical device for the replacement of pulsatile circulation by pulseless circulation for patients awaiting heart transplantation. The Continuous flow total artificial heart (CFTAH) is a device consisting of two continuous ventricular assist devices that produce pulseless flow into both systemic and pulmonary circulation. Its utilization is not yet widespread. The Continuous flow total artificial heart has only been implanted in humans three times as an off-label use of a ventricular assist device. All three men have been supported by chronic pulseless flow. The issue of chronic pulseless vs. chronic pulsatile blood flow and its effects on organs and tissue perfusion has been debated in medical and biomedical scientific journals for decades. There are many animal studies, views of many scientists and many hypotheses, but no clear answer to the basic question: will a person be able live a quality life with pulseless flow for months and years?
Klasifikace
Druh
D - Stať ve sborníku
CEP obor
—
OECD FORD obor
20301 - Mechanical engineering
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název statě ve sborníku
World Congress on Medical Physics and Biomedical Engineering, June 7-12, 2015, Toronto, Canada
ISBN
978-3-319-19387-8
ISSN
1680-0737
e-ISSN
—
Počet stran výsledku
4
Strana od-do
318-321
Název nakladatele
Springer International Publishing AG
Místo vydání
Cham
Místo konání akce
Toronto, Canada
Datum konání akce
7. 6. 2015
Typ akce podle státní příslušnosti
WRD - Celosvětová akce
Kód UT WoS článku
—